Learn More
BACKGROUND Locally advanced oesophageal cancer (LAEC) is associated with poor survival and more effective treatments are needed. The aim of this phase I trial was to assess the maximum tolerated dose (MTD) of a novel weekly docetaxel and cisplatin regimen concurrent with radical radiotherapy. METHODS Patients with unresectable, non-metastatic LAEC were(More)
—G.fast is an upcoming next generation DSL standard envisioned to use bandwidth up to 212 MHz. Far-end crosstalk (FEXT) at these frequencies greatly overcomes direct links. Its cancellation based on non-linear Tomlinson-Harashima Precod-ing (THP) proved to show significant advantage over standard linear precoding. This paper proposes a novel THP structure(More)
Standard chemoradiotherapy with infusional 5FU for locally advanced pancreatic cancer (LAPC) has limited efficacy in this disease. The combination of Capecitabine (Cap) and Gemcitabine (Gem) are synergistic and are potent radiosensitisers. The aim of this phase I trial was thus to determine the highest administered dose of the Cap plus Gem combination with(More)
—Centralized Radio Access Network (C-RAN) architecture is the only viable solution to handle the complex interference scenario generated by massive antennas and small cells deployment as required by next generation (5G) mobile networks. In conventional C-RAN, the fronthaul links used to exchange the signal between Base Band Units (BBUs) and Remote Antenna(More)
  • Mario Cioce, Severine Boulon, A Matera, Gregory, Angus I Lamond
  • 2017
General rights Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication(More)
  • 1